$GeneDx Holdings (WGS.US)$ 10% Shareholder Casdin Capital, LLC purchased 130K shares of common stock on Jun 3, 4, 2024 at an average price of $21.2086 for a total value of $2.76 million.
This transaction involves other related parties: Casdin Eli, Casdin Partners Master Fund, L.P., Casdin Partners GP, LLC and Casdin Partners FO1-MSV, LP.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.